Cargando…

rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling

Background: Pulmonary hypertension (PH) is a progressive cardiovascular disease, characterized by endothelial and smooth muscle dysfunction and vascular remodeling, followed by right heart failure. Group III PH develops secondarily to chronic lung disease such as idiopathic pulmonary fibrosis (IPF),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rathinasabapathy, Anandharajan, Bryant, Andrew J., Suzuki, Toshio, Moore, Christy, Shay, Sheila, Gladson, Santhi, West, James D., Carrier, Erica J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922219/ https://www.ncbi.nlm.nih.gov/pubmed/29731719 http://dx.doi.org/10.3389/fphys.2018.00271

Ejemplares similares

Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
por: Qiu, Zeping, et al.
Publicado: (2021)

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2020)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
por: West, James, et al.
Publicado: (2021)

RhACE2 – playing an important role in inhibiting apoptosis induced by Ang II in HUVECs
por: Zhang, Hongli, et al.
Publicado: (2019)

Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021)

The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)

Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection
por: Soheili, Marzieh, et al.
Publicado: (2020)

Ubiquitin chains: a new way of screening for regulatory differences in pulmonary hypertension
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)

Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure
por: Muslim, Shahnawaz, et al.
Publicado: (2020)

KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models
por: West, James D., et al.
Publicado: (2021)

Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling
por: Pickworth, Josephine, et al.
Publicado: (2017)

Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension
por: West, James D., et al.
Publicado: (2016)

Rapid disease progress in a PVOD patient carrying a novel EIF(2)AK(4) mutation: a case report
por: Zeng, Xiaofang, et al.
Publicado: (2020)

Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition
por: Suzuki, Toshio, et al.
Publicado: (2017)

ACE2 trials suggest remodeling, not dilation, as primary therapeutic effect
por: West, James
Publicado: (2022)

Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report
por: Zeng, Xiaofang, et al.
Publicado: (2023)

Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China
por: Zeng, Xiaofang, et al.
Publicado: (2021)

Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
por: Lutchman, Dhamend
Publicado: (2020)

Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
por: West, James, et al.
Publicado: (2020)

Fisetin Alleviated Bleomycin-Induced Pulmonary Fibrosis Partly by Rescuing Alveolar Epithelial Cells From Senescence
por: Zhang, Li, et al.
Publicado: (2020)

The Effects of Chemotherapeutic Agents, Bleomycin, Etoposide, and Cisplatin, on Chromatin Remodeling in Male Rat Germ Cells
por: Bagheri-Sereshki, Negar, et al.
Publicado: (2016)

Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice
por: Nikitopoulou, Ioanna, et al.
Publicado: (2019)

Extracellular matrix remodeling associated with bleomycin-induced lung injury supports pericyte-to-myofibroblast transition
por: Hannan, Riley T., et al.
Publicado: (2020)

Exercise Improves Lung Inflammation, but Not Lung Remodeling and Mechanics in a Model of Bleomycin-Induced Lung Fibrosis
por: El-Mafarjeh, Elias, et al.
Publicado: (2020)

Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho(–/–) mouse
por: Palfi, Arpad, et al.
Publicado: (2015)

Pulmonary toxicity of bleomycin.
por: Adamson, I Y
Publicado: (1976)

Bleomycin and misonidazole cytotoxicity.
por: Korbelik, M., et al.
Publicado: (1985)

Ketone Bodies Rescue Mitochondrial Dysfunction Via Epigenetic Remodeling
por: Gambardella, Jessica, et al.
Publicado: (2023)

Corrigendum to “Efficient gene delivery to photoreceptors using AAV2/rh10 and rescue of the Rho–/– mouse”
por: Palfi, Arpad, et al.
Publicado: (2016)

Qing Fei Hua Xian Decoction ameliorates bleomycin-induced pulmonary fibrosis by suppressing oxidative stress through balancing ACE-AngII-AT1R/ACE2-Ang-(1-7)-Mas axis
por: Li, Rui-jie, et al.
Publicado: (2023)

Radioimmunoassay of bleomycin in plasma and urine.
por: Teale, J. D., et al.
Publicado: (1977)

Fundamental and Clinical Studies of Bleomycin
por: Bleehen, N. M.
Publicado: (1977)

Bleomycin: A worthy alternative
por: Sandlas, Gursev, et al.
Publicado: (2011)

Is Bleomycin a worthy alternative?
por: Murthy, Jyotsna
Publicado: (2011)

Bleomycin-induced flagellate dermatitis
por: Mota, Guilherme Devidé, et al.
Publicado: (2014)

Immune ambivalence: The schizophrenic bleomycin
por: Mignot, Grégoire, et al.
Publicado: (2013)

Bleomycin induced hyperpigmentation of skin
por: Mishra, Kundan, et al.
Publicado: (2018)

Bleomycin-Induced Flagellate Dermatitis
por: Turan Erkek, Esra, et al.
Publicado: (2019)

Bleomycin‐induced flagellate hyperpigmentation
por: Larson, Krista N., et al.
Publicado: (2017)

Protective Role of the ACE2/Ang-(1–9) Axis in Cardiovascular Remodeling
por: Ocaranza, María Paz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1qnbr7jfv3gk2mj8t5sfk3l5gg